Pheton Holdings Price to Sales Ratio 2023-2024 | PTHL
Historical PS ratio values for Pheton Holdings (PTHL) over the last 10 years. The current P/S ratio for Pheton Holdings as of May 20, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Pheton Holdings P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-21 | 5.14 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.031B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.538B | 26.55 |
| Elevance Health (ELV) | United States | $93.196B | 12.03 |
| CVS Health (CVS) | United States | $80.632B | 10.02 |
| Cencora (COR) | United States | $56.777B | 19.75 |
| DiDi Global (DIDIY) | China | $22.309B | 33.86 |
| Natera (NTRA) | United States | $21.101B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.924B | 13.68 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.447B | 0.00 |
| CochLear (CHEOY) | Australia | $11.597B | 0.00 |
| Revvity (RVTY) | United States | $11.030B | 18.98 |
| ICON (ICLR) | Ireland | $10.666B | 9.92 |
| Viatris (VTRS) | United States | $10.422B | 3.58 |
| Doximity (DOCS) | United States | $9.895B | 46.09 |
| Avantor (AVTR) | United States | $9.179B | 13.34 |
| Medpace Holdings (MEDP) | United States | $8.813B | 23.41 |
| HealthEquity (HQY) | United States | $8.752B | 43.06 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.050B | 13.81 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.153B | 24.48 |
| BrightSpring Health Services (BTSG) | United States | $4.151B | 38.42 |
| Sotera Health (SHC) | United States | $3.639B | 20.68 |
| Alignment Healthcare (ALHC) | United States | $3.102B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.973B | 38.67 |
| Concentras Parent (CON) | United States | $2.889B | 16.70 |
| Organon (OGN) | United States | $2.277B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.164B | 9.23 |
| GeneDx Holdings (WGS) | United States | $2.058B | 79.24 |
| Premier (PINC) | United States | $1.902B | 14.44 |
| Progyny (PGNY) | United States | $1.875B | 41.26 |
| PACS (PACS) | United States | $1.606B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.418B | 28.36 |
| Pediatrix Medical (MD) | United States | $1.302B | 9.91 |
| Teladoc Health (TDOC) | United States | $1.288B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.089B | 0.00 | |
| Agilon Health (AGL) | United States | $1.027B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.988B | 15.43 |
| Nutex Health (NUTX) | United States | $0.986B | 14.90 |
| AMN Healthcare Services Inc (AMN) | United States | $0.878B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.84 |
| InnovAge Holding (INNV) | United States | $0.572B | 0.00 |
| Enhabit (EHAB) | United States | $0.537B | 44.21 |
| Auna S.A (AUNA) | Luxembourg | $0.518B | 11.67 |
| LifeMD (LFMD) | United States | $0.484B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| SBC Medicals (SBC) | United States | $0.368B | 0.00 |
| Beauty Health (SKIN) | United States | $0.212B | 0.00 |
| Oncology Institute (TOI) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.210B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| KindlyMD (KDLY) | United States | $0.092B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |